The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on the Henry Ford Health System.
Kus
D
D
Ambulatory Pharmacy Services, Henry Ford Health System, Detroit, USA.
D000897:Anti-Ulcer Agents / Q000191:economics / Q000627:therapeutic use*; D003659:Decision Making, Organizational; D019033:Delivery of Health Care, Integrated / Q000191:economics / Q000458:organization & administration*; D016527:Drug Costs; D004791:Enzyme Inhibitors / Q000191:economics / Q000627:therapeutic use*; D005569:Formularies as Topic; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D007324:Institutional Management Teams; D008824:Michigan; D016134:Organizational Policy; D054328:Proton Pump Inhibitors
D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors